approves

The U.S. Food and Drug Administration approved Acadia Pharmaceuticals Inc’s drug for the treatment of Rett syndrome, a genetic brain disorder, the company said on Friday, making it the first approved drug for the condition. The U.S. health regulator’s decision allows use of the trofinetide, to be sold under the brand name Daybue...

Fannie Mae has approved six firms to handle its new valuation initiative, which cuts traditional appraisers out of the process and potentially represents the...

With Clinical Laboratory Evaluation Program assay validation, the company's Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples. WHY IT MATTERS Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible. "Consistent with our mission of improving healthcare